Publications by authors named "Andria Gm Langenberg"
A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies.
Ayman Al-Hendy Andrea S Lukes Alfred N Poindexter Roberta Venturella Claudio Villarroel Andria Gm Langenberg
Pain Manag
April 2023
Article Synopsis
- The LIBERTY 1 and LIBERTY 2 studies evaluated the effectiveness of relugolix combination therapy in reducing heavy menstrual bleeding in women with uterine fibroids compared to a placebo.
- Approximately 73% of women in LIBERTY 1 and 71% in LIBERTY 2 experienced significant reductions in menstrual blood loss after 24 weeks of treatment.
- Common side effects included headaches and hot flushes, but overall, the side effects were comparable among the treatment and placebo groups.